Debt-to-equity of IMMUNIC, INC. from 31 Mar 2020 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
IMMUNIC, INC. quarterly Debt-to-equity in % history and change rate from 31 Mar 2020 to 30 Sep 2025.
  • IMMUNIC, INC. Debt-to-equity for the quarter ending 30 Sep 2025 was 184%, a 333% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

IMMUNIC, INC. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 184% +142% +333% 30 Sep 2025
Q2 2025 113% +74% +189% 30 Jun 2025
Q1 2025 80% +44% +120% 31 Mar 2025
Q4 2024 43% +9% +27% 31 Dec 2024
Q3 2024 43% +21% +97% 30 Sep 2024
Q2 2024 39% +22% +135% 30 Jun 2024
Q1 2024 36% +24% +194% 31 Mar 2024
Q4 2023 34% +24% +239% 31 Dec 2023
Q3 2023 22% +12% +131% 30 Sep 2023
Q2 2023 17% +8% +94% 30 Jun 2023
Q1 2023 12% +3% +30% 31 Mar 2023
Q4 2022 10% 0% -4.5% 31 Dec 2022
Q3 2022 9% 0% -0.42% 30 Sep 2022
Q2 2022 9% 0% -1.7% 30 Jun 2022
Q1 2022 10% +1% +17% 31 Mar 2022
Q4 2021 11% +3% +43% 31 Dec 2021
Q3 2021 9% 0% +4.3% 30 Sep 2021
Q2 2021 9% -3% -28% 30 Jun 2021
Q1 2021 8% -2% -21% 31 Mar 2021
Q4 2020 7% 31 Dec 2020
Q3 2020 9% 30 Sep 2020
Q2 2020 12% 30 Jun 2020
Q1 2020 10% 31 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.